News

Filter

Current filters:

Aires Pharmaceuticals

Aires Pharma signs option deal with Novartis based on Aironite worth up to $250 million; raises $20 million

12-11-2010

Privately-held, US clinical stage pharmaceutical company Aires Pharmaceuticals had a successful fundraising…

Aires PharmaceuticalsAironiteFinancialLicensingMergers & AcquisitionsNovartisPharmaceuticalRespiratory and Pulmonary

Back to top